Pulmonary coccidioidomycosis
ICD-10 B39.2 is a billable code used to indicate a diagnosis of pulmonary coccidioidomycosis.
Pulmonary coccidioidomycosis is a fungal infection caused by the inhalation of spores from the Coccidioides species, primarily C. immitis and C. posadasii. This condition is endemic to certain regions, particularly the southwestern United States, parts of Mexico, and Central and South America. The infection can range from asymptomatic to severe pulmonary disease, with symptoms including cough, fever, chest pain, and difficulty breathing. In immunocompromised patients, such as those with HIV/AIDS, cancer, or those on immunosuppressive therapy, the risk of disseminated disease increases significantly. Diagnosis is typically confirmed through serological tests, culture, or histopathological examination. Treatment often involves antifungal medications such as fluconazole or itraconazole, with amphotericin B reserved for severe cases. Early recognition and appropriate management are crucial to prevent complications, especially in vulnerable populations.
Detailed patient history, exposure history, lab results, and treatment plans.
Patients presenting with respiratory symptoms after travel to endemic areas.
Ensure documentation reflects the severity and treatment response.
Pulmonary function tests, imaging studies, and treatment response documentation.
Patients with chronic cough and respiratory distress.
Document any co-morbid respiratory conditions.
Used to confirm diagnosis in suspected cases.
Document the reason for testing and results.
Infectious disease specialists should ensure comprehensive lab documentation.
Common symptoms include cough, fever, chest pain, and difficulty breathing. Some patients may be asymptomatic.
Diagnosis is typically made through serological tests, culture, or imaging studies that reveal pulmonary involvement.
Common antifungal treatments include fluconazole, itraconazole, and amphotericin B for severe cases.
Immunocompromised patients are at higher risk for severe disease and may require different treatment protocols.
